Huperzine A for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Yang, Guoyan ^a   Wang, Yuyi ^a   Tian, Jinzhou ^a   Liu, Jian Ping ^a  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; DONEPEZIL; GALANTAMINE; HERBACEOUS AGENT; HUPERZINE A; PIRACETAM; PLACEBO;

ABDOMINAL PAIN; ACTIVITIES OF DAILY LIVING SCALE; ALZHEIMER DISEASE; ALZHEIMER DISEASE ASSESSMENT SCALE; ALZHEIMER DISEASE COOPERATIVE STUDY ACTIVITIES OF DAILY LIVING INVENTORY; ANOREXIA; ARTICLE; BRADYCARDIA; COGNITION; CONSTIPATION; DAILY LIFE ACTIVITY; DIARRHEA; DIZZINESS; EDEMA; EXCITABILITY; HASTGAWA DEMENTIA SCALE; HUMAN; HYPERACTIVITY; INSOMNIA; META ANALYSIS; MINI MENTAL STATE EXAMINATION; NAUSEA; NOSE OBSTRUCTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RATING SCALE; SIDE EFFECT; SOMNOLENCE; SWEATING; SYSTEMATIC REVIEW; THIRST; VOMITING; WECHSLER MEMORY SCALE;

ALKALOIDS; ALZHEIMER DISEASE; HUMANS; PLACEBOS; PUBLICATION BIAS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SESQUITERPENES;

EID: 84884528895     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074916     Document Type: Article

References (39)

1. Hanns H, Gabriele N, (2003) The discovery of Alzheimer's disease. Dialogues Clin Neurosci 51: 101-108.
2. Christiane R, Carol B, Richard M, (2011) Epidemiology of Alzheimer disease. Nat Rev Neurol 73: 137-152.
3. Alzhermer's Disease International (2009) World Alzhermer Report: World Alzhermer Report 2009. Available: http://www.alz.co.uk/research/world-report. Accessed 28 January 2013.
4. Alzhermer's Disease International (2012) World Alzhermer Report: World Alzhermer Report 2012. Available at: http://www.alz.co.uk/research/world-report. Accessed 28 January 2013.
5. Alzheimer's Association. FDA-Approved Treatment for Alzheimer's. Available at: http://www.alz.org. Accessed 29 January 2013.
6. Wang YE, Yue DX, Tang XC, (1986) Anti-Cholinesterase Activity of Huperzine-A. Acta Pharmacology Sinica 7: 110-113.
7. Li J, Wu HM, Zhou RL, Liu GJ, Dong BR (2008) Huperzine A for Alzheimer's disease. Cochrane Database of Systematic Reviews DOI: 10.1002/14651858. CD005592.pub2.
8. Li-Min F, Ju-Tzu L (2011) A systematic review of single Chinese herbs for Alzheimer's disease treatment. Evid Based Complement and Alternat Med DOI: 10.1093/ecam/nep136.
9. Yang GY, Wang YY, Xia Y, Tian JZ, Liu JP (2012) Huperzine A preparation for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials. PROSPERO: CRD42012003249. Available: http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42012003249. Accessed 28 January 2013.
10. The metaRegister of Controlled Trials. Available at: www.controlled-trials.com. Accessed 28 January 2013.
11. The ClinicalTrials.gov trials registry. Available: www.clinicaltrials.gov. Accessed 28 January 2013.
12. The Australian New Zealand Clinical Trials Registry. Available: www.anzctr.org.au. Accessed 28 January 2013.
13. The World Health Organization International Clinical Trials Registry platform. Available: www.who.int/trialsearch. Accessed 28 January 2013.
14. CentreWatch. Available: http://www.centerwatch.com/. Accessed 28 January 2013.
15. Higgins JPT, Altman DG, Sterne JAC, editors (2011) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration. Available: www.cochrane-handbook.org. Accessed 28 January 2013.
16. Rafii MS, Walsh S, Little JT, Behan K, Reynolds B, et al. (2011) A phase II trial of huperzine A in mild to moderate Alzheimer disease. Neurology 76: 1389-1394.
17. Xu SS, Gao ZX, Weng Z, Du ZM, Xu WA, et al. (1995) Efficacy of tablet huperzine-A on memory, cognition and behavior in Alzheimer's disease. Acta Pharmacologica Sinica 16: 391-395.
18. Zhou BR, Xu ZQ, Kuang YF, Deng YH, Qian CY, (2004) Curative effect of aspirin for postponing the development of Alzheimer's disease. Chinese Journal of Clinical Rehabilitation 8: 3020-3021.
19. Zhou BR, Xu ZQ, Kuang YF, Deng YH, Liu ZF, (2004) Effectiveness of polydrug therapy for senile dementia. Chinese Journal of Clinical Rehabilitation 8: 1214-1215.
20. Liu FG, Fang YS, Gao ZX, Zhou JD, Su ML, (1995) Double-blind control treatment of huperzine-A and placebo in 28 patients with Alzheimer disease. Chinese Journal of Pharmacoepidemiology 4: 196-198.
21. Zhang ZX, Wang XD, Chen QT, Shu L, Wang JZ, et al. (2002) Clinical efficacy and safety of huperzine A in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial. National Medical Journal of China 82: 941-944.
22. Li WN, Yu HY, (2011) The efficacy of Huperzine A in treating mild to moderate Alzheimer's disease. Chinese Journal of Gerontology 31: 2096-2097.
23. Yang CY, Lu ZP, Zheng CG, (2003) Efficacy and reliability of huperzine A in mild and moderate Alzheimer's disease. Chinese Journal of Clinical Rehabilitation 7: 4258-4259.
24. Chai XS, Weng Z, Zhao CY, Zhang SJ, (1998) A double-blinded randomized controlled trials on Shuang Yi Ping (Huperzine A) in treating Alzheimer's disease. Shanghai Medical & Pharmaceutical Journal 1: 16-17.
25. Shi BH, Li YF, Li CY, Shi W, Chen XH, (2013) Clinical study of huperzine A on patients with mild and moderate Alzheimer disease. Practical Pharmacy And Clinical Remedies 16: 37-38.
26. Qin HY, Qu ZF, (2008) The relationship between the serum concentration of CHE, SOD and cognitive function in Alzheimer's disease versus vascular dementia. Shanghai Archives of Psychiatry 20: 339-341.
27. Chen YM, Ma YX, Chen MJ, Fang YS, Chai XS, et al. (2000) Observation of aniraletam and huperzine on memory function of Alzheimer's disease. Modern Rehabilitation 4: 1622-1623.
28. Dong HT, Jin YG, Bai Y, (2002) Acupuncture for Alzheimer's disease in 11 cases. ACTC Universitatis Traditionis Medicalis Sinensis Pharmacologiaeque Shanghai 16: 26-28.
29. Gu P, Jin QW, Ding XS, Wang Y, Li HJ, (2000) Observation of effect on Alzheimer disease treated by Galanthamine hydrobromide capules. Practical Geriatrics 14: 307-308.
30. Jia YP, Bai X, Zhang YH, Liu XY, (2010) The observation of Alzhermer's disease by different rules based on blood stasis therapeutic dialectical principle. Chinese Journal of Integrative Medicine on Cardio-/Cerebrovascular Disease 8: 37-39.
31. Kuang MZ, Xiao WM, Wang SF, Li RX, (2004) Clinical evaluation of huperzine A in improving intelligent disorder in patients with Alzheimer's disease. Chinese Journal of Clinical Rehabilitation 8: 1216-1217.
32. Liu JN, Huang ZY, Zhou YN, Ju YL, (1998) The clinical observation of Alzheimer's disease treated by Huperzine A. Chinese Journal of Clinical Pharmacy 7: 270-272.
33. Huang MZ, Jin F, Zeng JM, (2005) Clinic evaluation of huperzine A tablets treating serious Alzheimer's disease for a period of six months. Chinese Medical Journal of Metallurgical Industry 22: 377-378.
34. Yang J, Yang CY, Song C, (2012) The effect of Donepezil and Huperzine A in treating Alzheimer's disease. Chinese Journal of Gerontology 32: 4631-4633.
35. Wang WS, Lv JH, Hao ZH, Zhao HF, Tang Z, (2009) Clinical study on treatment of dementia by integrative medicine. China Medicine 4: 800-801.
36. Schulz KF, Altman DG, Moher D, (2010) CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials. BMJ 340: c332.
37. Chen W, Lim CED, Kang HJ, Liu JP, (2011) Chinese herbal medicine for the treatment of Type A H1N1 influenza: a systematic review of randomized controlled trials. PLOS ONE 6: e28093.
38. Robert P, Ferris S, Gauthier S, Ihl R, Winblad B, (2010) Review of Alzheimer's disease scales: is there a need for a new multi-domain scale for therapy evaluation in medical practice? Alzheimer's Research & Therapy 2: 24.
39. Tian JZ, Shi J, Zhang XK, Wang YY, (2010) Herbal therapy: a new pathway for the treatment of Alzheimer's disease. Alzheimer's Research & Therapy 2: 30.